New products and changes introduced over the last week include the Goldman Sachs Small/Mid Cap Value Fund; the Perritt Low Priced Stock Fund; an expanded advisory role for the advisor of the Vanguard Windsor II Fund; a new version of LPL Financial’s Portfolio Manager; and an integrated platform for Wells Fargo’s health savings accounts and 401(k) services.
In addition, NASDAQ OMX announced expanded availability of some of its global indexes; AdvisorShares announced the launch for its YieldPro ETF; Envestnet launched liquid endowment portfolios; First Trust launched the Dorsey Wright Focus 5 ETF; and Scivantage launched the next generation of its Scivantage Investor platform.
Here are the latest developments of interest to advisors:
1) Goldman Sachs Asset Management Launches Small/Mid Cap Value Fund
Goldman Sachs Asset Management (GSAM) has announced the launch of the Goldman Sachs Small/Mid Cap Value Fund (GMVAX, A shares; GSMVX, I shares). The fund seeks long-term capital appreciation in a portfolio of small- and mid-cap securities that portfolio management believes are undervalued and have potential attractive risk-reward profiles.
Top 10 Stocks To Watch Right Now: Nam Tai Electronics Inc.(NTE)
Nam Tai Electronics, Inc. provides electronics manufacturing and design services to the original equipment manufacturers of telecommunication and consumer electronic products. The company?s Consumer Electronic and Communication Products segment manufactures mobile phone accessories, such as headsets containing Bluetooth wireless technology, and phone cradles, as well as snap-on portable music speaker, FM radio adaptors, and GPS adaptors; entertainment devices, including USB Web cam for interactive games, USB microphone and converter box Karaoke, and buzzer devices for quiz games; educational products consisting of digital pens, calculators, and electronic dictionaries; and optical devices comprising CMOS imaging sensor modules for notebook computers, portable media players, and recording cameras for the automotive industry. Its Telecommunication Component Assembly segment offers subassemblies and components, such as color and monochrome LCD modules for PDA phones, smart p hones, mobile phones, and telephone systems; RF modules for integration into mobile phones; DAB modules for digital radio products, including home tuners, kitchen radios, in-car receivers, CD players, clock radios, boom boxes, midi-systems, and handheld portable devices; FPC subassemblies for LCD modules and electronic devices; FPC boards for mobile phones, PDAs, office automation, and laptop computers; front and back light panels for handheld video game devices; and high-frequency cordless telephones and home feature phones. The company?s LCD Products segment manufactures LCD panels for watches and medical instruments, white goods and industrial applications, automotive parts and appliances, car audio systems, hand held products, VoIP phones, and office automation applications. It sells its products to customers in Hong Kong, North America, Europe, Japan, the People?s Republic of China, and Korea. The company was founded in 1975 and is headquartered in Shenzhen, the Peopl e?s Republic of China.
Advisors' Opinion:- [By Roberto Pedone]
Another stock that's starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world's leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.
If you look at the chart for Nam Tai Electronics, you'll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.
Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.
Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Low Price Stocks To Own For 2014: Tractebel Energia SA (TBLE3)
Tractebel Energia SA (Tractebel Energia) is a Brazil-based company involved in the energy sector. The Company is engaged in the generation and sale of electric power generated by its assets or acquired through near and long-term agreements. In addition, it provides online customer services to its customers. Tractebel Energia operates power plants in the Brazilian states of Santa Catarina, Rio Grande do Sul, Parana, Sao Paulo, Mato Grosso do Sul, Mato Grosso, Goias, Ceara, Piaui, Minas Gerais, Tocantins and Maranhao. The Company generates energy through hydroelectric power plants, thermoelectric plants, small hydroelectric power plants, wind farms and biomass fired power plants. The Company is controlled by GDF SUEZ Energy Latin America Participacoes Ltda. Advisors' Opinion:- [By Patricia Lara]
The state-run water company�� market value rose to a record $11.1 billion at the end of last month, narrowing the gap to generator Tractebel Energia SA (TBLE3) to about $360.7 million, data compiled by Bloomberg show. That�� down from $1 billion at the end of last year and $3.89 billion at the start of 2012.
Best Low Price Stocks To Own For 2014: Infinity Pharmaceuticals Inc.(INFI)
Infinity Pharmaceuticals, Inc. engages in the discovery and development of medicines for difficult-to-treat diseases. The company?s lead product candidates include saridegib (IPI-926), an oral molecule with the potential to treat a range of cancers by disrupting malignant activation of the Hedgehog pathway; and Retaspimycin HCl (IPI-504), a heat shock protein 90 (Hsp90) inhibitor. Its Saridegib is in a Phase II clinical trial for the treatment of metastatic or inoperable chondrosarcoma and a Phase II exploratory trial in patients with myelofibrosis. The company?s Retaspimycin HCl is in a Phase II trial in combination with docetaxel to treat patients with non-small cell lung cancer (NSCLC); and in a Phase Ib/II trial in combination with everolimus, known as Afinitor, in approximately 45 NSCLC patients with a KRAS mutation. Its pipeline also includes IPI-145, an inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) in Phase I development to treat in flammation and hematologic malignancies. Infinity Pharmaceuticals has a strategic alliance with Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Limited to develop and commercialize pharmaceutical products; and a development and license agreement with Millennium to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K, including IPI-145. Purdue Pharmaceutical Products is planning to conduct Phase II studies of IPI-940 in pain. The company is headquartered in Cambridge, Massachusetts.
Advisors' Opinion:- [By Ben Levisohn]
Knapp and Slover were also kind enough to provide a screen of stocks that could outperform. They started with the Russell 2000, removed the smallest 40% based on market cap (the aforementioned liquidity issues), then selected the 5% worst performers from among the 30% cheapest stocks based on book-to-price. The result is a bunch of names you never heard of, including Infinity Pharmaceuticals (INFI), Fusion-IO (FIO), Walter Energy (WLT), Hecla Mining (HL) and Molycorp�(MCP).
Best Low Price Stocks To Own For 2014: HCC Insurance Holdings Inc. (HCC)
HCC Insurance Holdings, Inc. underwrites non-correlated specialty insurance products worldwide. The company operates in five segments: U.S. Property & Casualty, Professional Liability, Accident & Health, U.S. Surety & Credit, and International. The U.S. Property & Casualty segment provides aviation, small account errors and omissions liability (E&O), public risk, contingency, disability, residual value, employment practices liability (EPLI), technical property, primary and excess casualty, and brown water marine insurance products, as well as title and mortgage reinsurance products in the United States. The Professional Liability segment offers directors� and officers� (D&O) liability, large account E&O liability, fiduciary liability, fidelity and bankers blanket bonds, and EPLI for the United States and International-based policyholders. The Accident & Health segment provides medical stop-loss, short-term domestic and international medical, HMO reinsurance, and medical excess coverages in the United States. The U.S. Surety & Credit segment offers contract surety bonds, commercial surety bonds, and bail bonds; credit insurance policies for export trade transactions and structured trade transactions; and political risk and letters of credit insurance products. The International segment provides energy, property treaty, liability, surety, credit, direct and facultative property, ocean marine, accident and health, and other smaller product lines for international customers. The company markets its products directly to consumers, as well as through a network of independent agents and brokers, producers, and managing general agents. HCC Insurance Holdings, Inc. was founded in 1974 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Ben Levisohn]
Shares of American International Group have dropped 1.7% to $49.67 at 1:19 p.m. today, while American Financial Group (AFG) has, dropped 0.2% to $57.23, HCC Insurance (HCC) is little changed at $45.12,�Travelers (TRV) has dipped 0.1% to $83.52 and Chubb (CB) is off 0.1% at $86.58.
- [By Ben Levisohn]
For the past several years, Berkshire has contrasted its own cost-free float provided by profitable underwriting against the industry�� (unimpressive) tendency to lose money on underwriting while generating net returns from investment income. So far, so good. Less edifying, though, is the repeated contrast of Berkshire�� track record of profitability to State Farm��…even though, as a mutual company, State Farm�� profitability goals are inherently different from for-profit insurers like Berkshire. It�� true that through year-end 2013, Berkshire�� underwriters have ��ow operated at an underwriting profit for eleven consecutive years,��but so have ACE (ACE), American Financial (AFG),� AmTrust Financial (AFSI), Arch Capital (ACGL), Chubb (CB), HCC (HCC), Progressive (PGR), RLI (RLI), and W.R. Berkley (WRB), any or all of whom provide a more meaningful comparison than contrasting Berkshire�� results to a company that�� not out to produce a profit in the first place.
No comments:
Post a Comment